These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30390361)

  • 1. Weight change and mortality: Long-term results from the trials of hypertension prevention.
    Cook NR; Appel LJ; Whelton PK
    J Clin Hypertens (Greenwich); 2018 Dec; 20(12):1666-1673. PubMed ID: 30390361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II.
    Stevens VJ; Obarzanek E; Cook NR; Lee IM; Appel LJ; Smith West D; Milas NC; Mattfeldt-Beman M; Belden L; Bragg C; Millstone M; Raczynski J; Brewer A; Singh B; Cohen J;
    Ann Intern Med; 2001 Jan; 134(1):1-11. PubMed ID: 11187414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. Trials of Hypertension Prevention (phase II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
    Hebert PR; Bolt RJ; Borhani NO; Cook NR; Cohen JD; Cutler JA; Hollis JF; Kuller LH; Lasser NL; Oberman A
    Ann Epidemiol; 1995 Mar; 5(2):130-9. PubMed ID: 7795831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
    Appel LJ; Hebert PR; Cohen JD; Obarzanek E; Yamamoto M; Buring J; Stevens V; Kirchner K; Borhani NO
    Ann Epidemiol; 1995 Mar; 5(2):149-55. PubMed ID: 7795833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
    Lasser VI; Raczynski JM; Stevens VJ; Mattfeldt-Beman MK; Kumanyika S; Evans M; Danielson E; Dalcin A; Batey DM; Belden LK
    Ann Epidemiol; 1995 Mar; 5(2):156-64. PubMed ID: 7795834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group.
    Arch Intern Med; 1997 Mar; 157(6):657-67. PubMed ID: 9080920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group.
    Stevens VJ; Corrigan SA; Obarzanek E; Bernauer E; Cook NR; Hebert P; Mattfeldt-Beman M; Oberman A; Sugars C; Dalcin AT
    Arch Intern Med; 1993 Apr; 153(7):849-58. PubMed ID: 8466377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium Intake and All-Cause Mortality Over 20 Years in the Trials of Hypertension Prevention.
    Cook NR; Appel LJ; Whelton PK
    J Am Coll Cardiol; 2016 Oct; 68(15):1609-1617. PubMed ID: 27712772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP).
    Cook NR; Cutler JA; Obarzanek E; Buring JE; Rexrode KM; Kumanyika SK; Appel LJ; Whelton PK
    BMJ; 2007 Apr; 334(7599):885-8. PubMed ID: 17449506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term effects of lifestyle change on blood pressure: One-year follow-up of the ENCORE study.
    Hinderliter AL; Sherwood A; Craighead LW; Lin PH; Watkins L; Babyak MA; Blumenthal JA
    Am J Hypertens; 2014 May; 27(5):734-41. PubMed ID: 24084586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight-loss experience of black and white participants in NHLBI-sponsored clinical trials.
    Kumanyika SK; Obarzanek E; Stevens VJ; Hebert PR; Whelton PK; Kumanyaka SK
    Am J Clin Nutr; 1991 Jun; 53(6 Suppl):1631S-1638S. PubMed ID: 2031498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of weight-reducing diets in hypertensive patients.
    Siebenhofer A; Jeitler K; Berghold A; Waltering A; Hemkens LG; Semlitsch T; Pachler C; Strametz R; Horvath K
    Cochrane Database Syst Rev; 2011 Sep; (9):CD008274. PubMed ID: 21901719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained Physical Activity, Not Weight Loss, Associated With Improved Survival in Coronary Heart Disease.
    Moholdt T; Lavie CJ; Nauman J
    J Am Coll Cardiol; 2018 Mar; 71(10):1094-1101. PubMed ID: 29519349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension.
    He J; Whelton PK; Appel LJ; Charleston J; Klag MJ
    Hypertension; 2000 Feb; 35(2):544-9. PubMed ID: 10679495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of weight-reducing drugs in people with hypertension.
    Siebenhofer A; Jeitler K; Horvath K; Berghold A; Posch N; Meschik J; Semlitsch T
    Cochrane Database Syst Rev; 2016 Mar; 3():CD007654. PubMed ID: 26934640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of weight loss and salt reduction on visit-to-visit blood pressure variability: results from a multicenter randomized controlled trial.
    Diaz KM; Muntner P; Levitan EB; Brown MD; Babbitt DM; Shimbo D
    J Hypertens; 2014 Apr; 32(4):840-8. PubMed ID: 24366034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion.
    Stolarz-Skrzypek K; Kuznetsova T; Thijs L; Tikhonoff V; Seidlerová J; Richart T; Jin Y; Olszanecka A; Malyutina S; Casiglia E; Filipovský J; Kawecka-Jaszcz K; Nikitin Y; Staessen JA;
    JAMA; 2011 May; 305(17):1777-85. PubMed ID: 21540421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress management intervention for primary prevention of hypertension: detailed results from Phase I of Trials of Hypertension Prevention (TOHP-I).
    Batey DM; Kaufmann PG; Raczynski JM; Hollis JF; Murphy JK; Rosner B; Corrigan SA; Rappaport NB; Danielson EM; Lasser NL; Kuhn CM
    Ann Epidemiol; 2000 Jan; 10(1):45-58. PubMed ID: 10658688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group.
    Whelton PK; Appel LJ; Espeland MA; Applegate WB; Ettinger WH; Kostis JB; Kumanyika S; Lacy CR; Johnson KC; Folmar S; Cutler JA
    JAMA; 1998 Mar; 279(11):839-46. PubMed ID: 9515998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
    Hollis JF; Satterfield S; Smith F; Fouad M; Allender PS; Borhani N; Charleston J; Hirlinger M; King N; Schultz R
    Ann Epidemiol; 1995 Mar; 5(2):140-8. PubMed ID: 7795832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.